Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 8

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 8
---
 under licensing arrangements; the
costs involved in prosecuting and enforcing patent claims and other intellectual property rights; and the costs and timing of regulatory
approvals.

    8

A fundamental component of the ability
to continue as a going concern is the Company’s ability to raise capital as required, as to which no assurances can be provided.
To address the additional funding requirements of the Company, management has undertaken the following initiatives:

    ●
    it has assessed its current expenditures and will reduce spending where necessary;

    ●
    it
will pursue additional capital funding in the public and private markets through equity sales and/or debt facilities;

    ●
    it
will pursue possible partnerships and collaborations; and

    ●
    it
will pursue potential out licensing for its drug candidates.

 The Company’s ability to
continue as a going concern will depend on its ability to raise additional capital, attain further operating efficiencies, reduce
expenditures, and, ultimately, to generate revenue. There are no assurances that these future funding and operating efforts will be
successful. If management is unsuccessful in these efforts, the Company’s current capital is not expected to be sufficient to fund our
operations for the next twelve months.

Management’s
plan includes private or public equity financings, collaborations, or other strategic transactions such as raising funds from outside
investors via its ATM program and other potential funding sources. The Company may not be able to obtain funding on acceptable terms,
or at all. The terms of any financing may adversely affect the holdings or the rights of the Company’s stockholders. The Company’s
ability to raise additional funds will depend, among other factors, on financial, economic and market conditions, many of which are outside
of its control, and it may be unable to raise financing when needed, or on terms favorable to the Company. If the Company is unable to
obtain sufficient capital to fund its operations it may be required to evaluate alternatives. The Company’s financial statements
do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification
of liabilities that may be required should the Company be unable to continue as a going concern.

Note 3. New Accounting Pronouncements 

From time to time, new accounting pronouncements are
issued by the FASB and are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes
that the impact of recently issued accounting pronouncements will not have a material impact on the Company’s consolidated financial
position